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Late endovascular aneurysm repair infection
presenting with juxatrenal aortic rupture treated
with in situ aortic replacement
Charles A. West Jr, MD,a Joseph Karam, MD,a Chad Poopat, MD,b Alexander D. Shepard, MD,a
Timothy J. Nypaver, MD,a and Mitchell Weaver, MD,a Detroit, Mich
Infection of an endovascular abdominal aneurysm repair (EVAR) is rare but has become more prevalent with the
standardization of EVAR for treating infrarenal abdominal aortic aneurysms. The understanding of this complex aortic
condition has improved but still remains to evolve. We present a patient with an EVAR infection manifesting with
juxtarenal aortic rupture as a result of a urinary tract infection. This report describes an unusual presentation of an EVAR
infection treated with in situ aortic reconstruction and provides >1 year of follow-up. (J Vasc Surg 2011;54:1157-60.)
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hInfection of an endovascular abdominal aneurysm re-
pair (EVAR) is a rare clinical problem, occurring in1% of
cases.1 Since the advent of EVAR, the epidemiology of
aortic stent graft infection has become evident with the
graduated use of the technique in the treatment of abdom-
inal aortic aneurysms (AAAs).2 Aortic stent graft infections
represent a complex aortic condition with significant mor-
bidity and high mortality.3,4 Although EVAR infections
may be similar conceptually to prosthetic aortic graft infec-
tions after open aortic procedures, more information is
necessary to understand the differences and improve out-
comes in the management of this vexing problem. We
report a patient with an unusual late EVAR infection pre-
senting with juxtarenal aortic rupture that was treated
successfully with in situ aortic reconstruction.
CASE REPORT
A 64-year-old man underwent EVAR of an AAA. In the
original procedure a 5.8-cm infrarenal AAA was treated by using a
26-  14-  12-mm Excluder endoprosthesis (W. L. Gore and
Associates, Flagstaff, Ariz) constructed of expanded polytetrafluo-
roethylene (ePTFE) and fluorinated ethylene propylene (FEP).
Surveillance computed tomography angiography (CTA) 1 year
after the operation revealed no evidence of endoleak and the sac
diameter had regressed to 4.5 cm (Fig 1). The patient was subse-
quently lost to follow-up.
At 4 years after EVAR, the patient presented with complaints
of progressive intermittent episodes of abdominal pain with asso-
ciated malaise and weight loss for 3 weeks. He was diagnosed with
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doi:10.1016/j.jvs.2011.04.008urinary tract infection and was treated with oral antibiotic ther-
py. Symptoms did not improve after 2 weeks of treatment, and the
atient required emergency department evaluation and hospital
dmission.
The physical examination documented abdominal tenderness
o palpation, and the patient appeared fatigued. Clinical laboratory
ata were significant for leukocytosis (white blood cell count of
2.3 K/L with 17.26 neutrophils), hyponatremia (serum so-
ium, 126 mmol/L), and a serum albumin level of 1.8 g/dL.
esults of subsequent blood cultures proved negative, but a uri-
ary tract infection was confirmed by urine culture yielding
100,000 colony-forming units) of Escherichia coli.
A computed tomography angiography (CTA) showed a con-
ained juxtarenal aortic rupture with loss of aortic wall integrity, a
hin crescent of marginal thrombus, and surrounding inflamma-
ion in the retroperitoneum (Fig 2). The contained rupture was
istinctly separate from the caudal native aneurysm sac, which had
emained stable. Small locules of air were noted around the graft
imbs, suggestive of EVAR infection (Fig 2).
Cardiopulmonary variables were normal; therefore, the pa-
ient was admitted to the intensive care unit for administration of
road-spectrum intravenous antibiotics, correction of electrolyte
mbalances, and nasogastric nutritional support. After 3 days of
ptimization, the patient underwent graft explantation, followed
y in situ aortic replacement. Exposure was through an eighth
nterspace thoracoabdominal (Pillsbury) incision and medial vis-
eral rotation. The paravisceral aorta was dissected and prepared
or supraceliac clamping. The juxtarenal aorta was aneurysmal,
iscolored, and severely inflamed up to the renal vessels.
On opening the aneurysm, periaortic hematoma was iden-
ified infiltrating the wall of the pseudoaneurysm cavity, and the
ortic wall was diffusely disintegrated. The purulent and non-
ncorporated graft was removed, and the retroperitoneum was de-
rided rapidly with antibiotic-saline pulse irrigation. Povidone-iodine
ponges were placed in the infected cavity, followed by placement of a
ifampin-soaked 18 9-mm gel-impregnated vascular prosthesis (30
g/mL).
The aortic anastomosis was sutured to a short remnant of
ealthy juxtarenal aortic tissue in an end-to-end fashion at the renal
rtery level. The lateral suture line stitches were taken through the
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October 20111158 West et allower ostial edges of the renal arteries. A large tongue of omentum
wasmobilized and oriented in an antecolic manner. Themain body
of the graft was wrapped 360° with omentum. The iliac artery graft
limbs were covered by omentum anteriorly and laterally. A feeding
gastrostomy tube was placed intraoperatively. Operative tissue
cultures were positive for rare Escherichia coli with a similar suscep-
tibility profile as the pathogen isolated from the preoperative urine
culture.
The patient’s postoperative course was uneventful, and after
14 days of hospitalization, he was dismissed with a 6-week course
of intravenous ceftriaxone, vancomycin, and supplemental gastric
feedings. Oral sulfamethoxazole/trimethoprim was also pre-
scribed for an indefinite time course.
A draining sinus tract developed from the chest wall incision at
3 months. This was treated conservatively with local debridement,
Fig 1. A, Axial image of computed tomography angiog
of the graft just below the renal vessels. B, Coronal imag
(white arrowheads). Note right (straight arrow) and left (
excluded with interval regression in size and no evidence
Fig 2. A, Axial image of computed tomography angiogr
with loss of aortic wall integrity, thin crescent of margin
toneum. B, Coronal image illustrates the juxtarenal locat
the native aneurysm sac (white arrowheads), which is un
renal arteries.but eventually, the infected costal cartilages required resection and gectus muscle flap reconstruction. A CT scan after 1 year demon-
trated a well-incorporated graft wrapped by autogenous tissue
Fig 3). The patient had complete restoration of functional status,
s back to normal activities, and continues to receive suppressive
ntibiotic therapy.
ISCUSSION
EVAR infections are rare and occur with a frequency of
.2% to 0.7% from large series.2 A bimodal distribution of
arly (4 months) and late infections (12 months) after
mplantation is recognized, with over half occurring after 1
ear.2 A variety of clinical manifestation appear, but most
atients present with abdominal and back pain, malaise,
nd weight loss in association with clinical signs of low
1 year after stenting shows the proximal fixation point
ws the proximal stent fixation and native aneurysm sac
d arrow) renal arteries. The aneurysm sac had remained
doleak.
at acute presentation illustrates contained aortic rupture
ombus, and surrounding inflammation in the retroperi-
f the rupture (black arrowheads) distinctly separate from
ed. Note right (straight arrow) and left (curved arrow)raphy
e sho
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Volume 54, Number 4 West et al 1159lieved to be related to contamination during the initial
implantation, early hematogenous spread from nosocomial
infections, or contamination during secondary interven-
tions.2 Staphylococcus aureus has been commonly identi-
fied; however, case reports have implicated a variety of
unusual pathogens, including Listeria monocytogenes, Can-
dida albicans, and Pasturella multocida.5-7 Our patient
presented with a urinary tract infection caused by E coli,
which has been rarely reported.
Combining clinical sign and symptoms with laboratory
(microbiology) data and imaging modalities most accu-
rately diagnoses EVAR infections.8 CTA has emerged as
the primary imaging modality to diagnose endovascular
infections due to its rapidity and availability.2 Findings of
late periaortic gas (1 month), fluid, and evidence of
periaortitis are classic features that support the diagnosis.2,8
The use of fluorodeoxyglucose positron-emission tomog-
raphy (FDG-PET) demonstrates focal regions of patho-
logic uptake (hot spots), which has been used as a diagnos-
tic criterion.8 This adjunct to CTA has been useful in
patients where obvious signs of infection and culture data
are ambiguous and CT findings are less obvious.8 Magnetic
resonance imaging and radiolabeled white blood cell scan-
ning have been used, but not as widely.
In general, principals in the treatment of aortic graft
infections include intravenous antibiotic therapy, extra-
anatomic bypass, followed by staged or simultaneous graft
removal or in situ aortic replacement with autogenous
tissue, an antibiotic-soaked prosthesis, or cryopreserved
allografts.9 Most reported EVAR infections have been
treated with traditional surgical methods of extra-anatomic
reconstruction and graft explantation.3,5-7 Reported mor-
tality rates after treatment for EVAR infection range from
20% to 40%, including those treated conservatively.4 In
2004, Ducasse et al10 reported 65 patients with EVAR
infection and found an 18% mortality rate after surgical
Fig 3. Computed tomography angiography at the 1-yea
prosthesis encircled by a 360° wrap of omentum. Note rtreatment. tTemporal delay in the treatment of a symptomatic
nfected aortic pseudoaneurysm may be controversial. Ini-
ially, our intention was to emergently repair the suspected
ontained rupture; however, we judged it critical to opti-
ize conditions prior to surgical repair given the untreated
ow grade sepsis. The presence of stable cardiopulmonary
arameters and improving symptoms of abdominal pain,
e believe, justified the interval delay.
In our patient, the extension of proximal infection with
vidence of contained native aortic rupture at the renal
rtery level was an ominous finding. Previous reports indi-
ate that aortic rupture is uncommon and has been noted in
10% of EVAR infections.2 In many of these reports, the
upture involved the infrarenal aneurysm sac contents
lone, and in others, rupture occurred from the iliac artery
r resulted from aortoenteric fistulization.11-12 At opera-
ion, severe inflammation of the pararenal aorta required
ore extensive exposure and supravisceral cross-clamping.
he proximal native aortic infection and aortic wall destruc-
ion, we discovered, precluded over-sewing the aortic
tump, and mandated the use of an in situ repair. A similar
bservation was made by Jackson et al,13 who reported
echnical hazards related to aortic inflammation and prox-
mal fixation components (hooks) in the first case of autol-
gous in situ aortic replacement with superficial femoral
ein for an EVAR infection.
In the majority of articles reporting on in situ replace-
ent after EVAR infection, the indications for the ap-
roach are vague. In situ aortic reconstruction for pros-
hetic aortic infections has been recommended when aortic
tump closure is difficult or when renal artery reconstruc-
ion may be required. The frequency of these specific
roblems has not been reported as a common surgical
ilemma in patients with traditional prosthetic aortic graft
nfections.14 Our case illustrates a clinical setting where in
itu aortic replacement was obligatory and predictable from
ow-up: (A) axial and (B) coronal images show the aortic
straight arrow) and left (curved arrow) renal arteries.r follhe outset. It is unclear whether future EVAR infections
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technical necessity.
Surveillance of patients with endografts during late
follow-up has been recommended.9 Reducing radiation
exposure, intensity of follow-up, and cost control in the
postoperative care of EVAR patients is desirable and has
been advocated.15 In the future, improving upon specific
risk factors identification for EVAR infection may prompt
earlier diagnostic investigations with modalities such as
FDG-PET, but currently no guidelines address the issue.
We gratefully acknowledge the Department of Henry
Ford Hospital media resources with special thanks to Mr
John J. Grybas for assisting with image design, intraopera-
tive photography, and processing.
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